Professor, Medicine, Indiana University School of Medicine

Infectious Disease

Doctor Darron R. Brown, MD practices Infectious Disease. He went to University of Rochester School of Medicine and Dentistry. Darron R. Brown is also published. He has 32 publications published. The lastest publication: "Clarification on the Impact of Cervarix Vaccination on Human Papillomavirus Infection and Cervical Cancer in the United Kingdom.'

Publications

---

• Clarification on the Impact of Cervarix Vaccination on Human Papillomavirus Infection and Cervical Cancer in the United Kingdom.
• Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for ...
• Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.
• Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.
• DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
• Association of Chlamydia trachomatis infection with Redetection of HPV after Apparent Clearance.
• Frequent Detection of Vaginal Human Papillomavirus Prior to first Sexual Intercourse during Longitudinal Observation.
• Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.
• Reduction of HPV infections through vaccination among at-risk urban adolescents.
• A molecular dynamics study of loop fluctuation in human papillomavirus type 16 virus-like particles: A possible indicator of immunogenicity.
• Advancing human papillomavirus research with a rhesus monkey model.
• The humoral response to Gardasil® over four years as defined by Total IgG and competitive Luminex immunoassay.
• Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
• Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
• A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital l...
• Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infe...
• Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
• The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV ...
• Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions.
• The human papillomavirus type 11 E1--E4 protein is a transglutaminase 3 substrate and induces abnormalities of the cornified cell envelope.
• Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women.
• Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas.
• Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.
• Progression from productive infection to integration and oncogenic transformation in human papillomavirus type 59-immortalized foreskin keratinocytes.
• A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.
• Human papillomavirus type 59 immortalized keratinocytes express late viral proteins and infectious virus after calcium stimulation.
• Infection with the oncogenic human papillomavirus type 59 alters protein components of the cornified cell envelope.
• Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men.
• Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic.
• Human papillomavirus type 11 alters the transcription and expression of loricrin, the major cell envelope protein.
• Expression of cytokeratin 16 in human papillomavirus type 11-infected genital epithelium.

Schools

---

• University Of Rochester School Of Medicine and Dentistry

• University Rochester

Doctors Specialties

---

• Infectious Disease Medicine
• Infectious Disease

Accepted Insurances

---

Education

---

• University of Rochester
• University of Rochester School of Medicine and Dentistry

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Richard B. Kohler, MD This Doctor is OpenDoctor Recommended.
	Dr. Byron E. Batteiger, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Keith E. Banks, MD This Doctor is OpenDoctor Recommended.
	Dr. Bradley L. Allen, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel J. Livorsi, MD This Doctor is OpenDoctor Recommended.
	Dr. Renita A. Brown, MD This Doctor is OpenDoctor Recommended.
	Dr. Janet N. Arno, MD This Doctor is OpenDoctor Recommended.
	Dr. Travis R. Hays, MD This Doctor is OpenDoctor Recommended.
	Dr. Herbert R. Mattison, MD This Doctor is OpenDoctor Recommended.
	Dr. Stanley M. Spinola, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Amy B. Kressel, MD This Doctor is OpenDoctor Recommended.
	Dr. Marjorie M. Conant, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog